FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEBSep 20, 2024 · FDA approves FluMist for self- or caregiver-administration. FluMist is approved for use in individuals 2 through 49 years of age for the prevention of influenza disease caused by influenza A ...
FDA Approves Self-Administration of Influenza Vaccine FluMist
WEB9 hours ago · The Food and Drug Administration (FDA) has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal). FluMist ® is a nasally-administered influenza ...
No needles required: The FDA approves an at-home flu vaccine
WEBSep 20, 2024 · No needles required: The FDA approves an at-home flu vaccine. A fifth-grader receives the FluMist influenza virus vaccine in Anaheim, Calif., in 2015. The Food and Drug Administration has approved ...
FDA approves first flu vaccine that can be self-administered at …
WEBSep 20, 2024 · The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. CNN —. The US Food and Drug Administration on Friday approved the first flu ...
FDA approves first self-administered flu vaccine spray - CBS News
WEBSep 20, 2024 · "Today's approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater ...
US FDA approves AstraZeneca's self-administered nasal spray flu …
WEBSept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...
FDA Approves First Flu Vaccine You Give Yourself at Home - U.S.
WEBSep 20, 2024 · Like any vaccine, side effects can occur with FluMist. According to the FDA, these include "fever over 100°F in children 2 through 6 years of age, runny nose and nasal congestion in individuals 2 ...
FDA approves first nasal spray flu vaccine for use at home
WEB6 days ago · FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old ...
US Will Transition to Trivalent Flu Vaccines for 2024-2025
WEBMar 8, 2024 · On March 5, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to discuss and make recommendations on the vaccine viruses for U.S. influenza vaccines for the 2024-2025 influenza season.
Use of Trivalent Influenza Vaccines for the 2024-2025 U.S.
WEBMar 5, 2024 · Based on the scientific evidence, and since the October 2023 VRBPAC meeting, FDA has been planning for the use of trivalent seasonal influenza vaccines for the U.S. for the 2024-2025...